DIVE
Dana Concentrated Dividend ETF
Dana Concentrated Dividend ETF seeks to provide investors with high current income and capital appreciation by investing primarily in a concentrated portfolio of dividend-paying U.S. companies.
US
EQUITY
Active
MANAGEMENT STYLE
$ 44.8 M
ASSETS UNDER MGMT
65 bp
EXPENSES
Fund Basics
| Inception date | Sep 16, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| PHILIP MORRIS INTERNATIONAL | 9.2 % |
| ALPHABET INC. CLASS A | 5.6 % |
| RESTAURANT BRANDS INTERNATIONAL INC | 4.8 % |
| IQVIA HOLDINGS INC | 4.3 % |
| AMAZON.COM INC | 4.2 % |
| ELEVANCE HEALTH INC | 4.1 % |
| KEURIG DR PEPPER INC. | 3.7 % |
| TRUIST FINANCIAL CORPORATION | 3.4 % |
| WELLS FARGO & CO | 3.4 % |
| META PLATFORMS INC | 3.3 % |
Constituent Breakdown
| Number of holdings | 33 |
| Herfindahl-Hirschman Index | 368 |
| Wgt avg mkt cap (mns) | $397,344 |
| Large cap (>$10bn) | 88.8% |
| Mid cap ($2-10bn) | 5.8% |
| Small cap (<$2bn) | 1.6% |
| Developed mkts. | 98.5% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.4 % |
 |
CANADA | 4.8 % |
 |
IRELAND | 1.3 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 1.8% | -- | -- | -- | -- | -- | -- | 31.4% |
| Dividend Yield | 0.4% | -- | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | 2.2% | -- | -- | -- | -- | -- | -- | 31.4% | Ann. Volatility | 14.7% | -- | -- | -- | -- | -- | -- | 35.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.70 | 7% |
| MSCI EAFE | 0.55 | 6% |
| MSCI Emg Mkts | 0.41 | 6% |
Liquidity Measures
| Avg. volume (000) | 3 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.16% |
Technical Indicators
| 30d moving avg. (EMA) | $25.42 |
| Relative strength (RSI) | 53 |
| MACD/Signal | 0.19/0.24 |
| Bollinger Bands (Upper/Lower) | $25.98/$25.31 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. DIVE |
Expenses vs. DIVE |
ALTAR Score™ vs. DIVE |
|---|---|---|---|---|
| LVDS | JPMorgan Fundamental Data Science Large Value ETF | 37.0% | -16 bp | -2.0% |
| FBCV | Fidelity Blue Chip Value ETF | 20.5% | -6 bp | -1.2% |
| QLTY | GMO U.S. Quality ETF | 20.1% | -15 bp | -3.1% |
| BLCV | iShares Large Cap Value Active ETF | 19.3% | -12 bp | -0.6% |
| DUSA | Davis Select U.S. Equity ETF | 19.3% | -4 bp | -0.5% |
| SPXT | ProShares S&P 500 Ex-Technology ETF | 19.3% | -56 bp | -2.2% |
| JAVA | JPMorgan Active Value ETF | 18.6% | -21 bp | -1.4% |
| SGLC | SGI U.S. Large Cap Core ETF | 18.5% | +20 bp | -3.2% |
| EPS | WisdomTree U.S. LargeCap Fund | 18.4% | -57 bp | -2.2% |
| CRTC | Xtrackers US National Critical Technologies ETF | 18.2% | -30 bp | -2.8% |
Risk and Returns: DIVE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/20/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.6%
ALTAR SCORE™
86th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,346 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. DIVE's ALTAR Score™ is approximately 1.1 standard
deviations above the category average. This places DIVE in the 86th percentile
among funds in the category.
Sell-Side Consensus
$30.25
PRICE TARGET
+18.5%
UPSIDE